Most Down Articles

    Published in last 1 year|In last 2 years|In last 3 years|All|Most Downloaded in Recent Month|Most Downloaded in Recent Year|

    In last 2 years
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Interpretation of the updated international guidelines for groin hernia management (2023)
    XU Jing, ZHUANG Qiulin, DONG Ruizhao, YANG Ziang
    Journal of Surgery Concepts & Practice 2024, 29 (04): 316-322. DOI:10.16139/j.1007-9610.2024.04.08
    Abstract874 HTML25 PDF(pc)(966KB)( 3105 Save

    Since theInternational guidelines for groin hernia managementwere published in 2018, many new evidences have been published. In October 2023, the HerniaSurge Group publishedUpdate of the international HerniaSurge guidelines for groin hernia management. It updated eight chapters of the last guidelines, proposed 20 key questions, and 39 new statements and 32 recommendations, of which 16 were strong recommendations. This article combined clinical concerns to sort out and interpret the updated version.

    Table and Figures|Reference|Related Articles|Metrics|Comments0
    Application and research prospects of artificial intelligence in breast cancer pathological diagnosis
    DA Qian, RUAN Miao, FEI Xiaochun, WANG Chaofu
    Journal of Surgery Concepts & Practice 2024, 29 (05): 389-395. DOI:10.16139/j.1007-9610.2024.05.04
    Abstract866 HTML54 PDF(pc)(1217KB)( 2199 Save

    Breast cancer is one of the most common cancers affecting women globally. With the advent of digital pathology slide scanners and the continuous evolution of deep learning algorithms, there has been a significant advancement in the application of artificial intelligence (AI) in the diagnosis and treatment of breast cancer. This article provided an overview of the current research and application status of AI in breast cancer pathological diagnosis, and summarized the challenges encountered as well as future directions in this field.

    Table and Figures|Reference|Related Articles|Metrics|Comments0
    Chinese interpretation of European Neuroendocrine Tumour Society 2023 guidance for nonfunctioning pancreatic neuroendocrine tumours
    HAN Liang, LIU Haonan, WU Zheng
    Journal of Surgery Concepts & Practice 2024, 29 (01): 14-26. DOI:10.16139/j.1007-9610.2024.01.04
    Abstract548 HTML3 PDF(pc)(962KB)( 1868 Save

    This ENETS guidance for well-differentiated nonfunctioning pancreatic neuroendocrine tumours (NF-Pan-NET), which published onJournal of Neuroendocrinology(2023), has been developed by a multidisciplinary working group, and provides up-to-date and practical advice on the management of these tumours. In this guideline, the authors discussed 10 troublesome questions about clinical practice, and summarized the extensive experience of their centers treating patients with NF-Pan-NET, and suggested that multidisciplinary participation is an essential part of NF-Pan-NET diagnosis and treatment. This paper aims to interpret the key contents of the guidelines in order to provide standardized clinical diagnosis and treatment procedures in NF-Pan-NET.

    Table and Figures|Reference|Related Articles|Metrics|Comments0
    Review and prospect of neoadjuvant chemoradiotherapy combined with immunotherapy in locally advanced rectal cancer
    WANG Yaqi, XIA Fan, ZHANG Zhen
    Journal of Surgery Concepts & Practice 2024, 29 (03): 220-229. DOI:10.16139/j.1007-9610.2024.03.07
    Abstract857 HTML8 PDF(pc)(978KB)( 1798 Save

    For locally advanced rectal cancer (LARC), the standard treatment of neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision (TME) leaded to limited tumor regression grade and organ preservation rate, and didn’t decrease the rate of distant metastasis. Radiotherapy can promote the immune response and has good synergistic effect with immunotherapy, which is likely to overcome the treatment difficulty of the microsatellite stable(MSS) colorectal cancer. Recently, multiple clinical trials are ongoing in terms of the combination of nCRT and immunotherapy in LARC. Most of them have achieved promising complete response rates, providing new treatment options for preservation of organ functions in mid-low MSS LARC. Large-scale randomized controlled trials are needed in the future to validate these findings and explore the benefit of organ preservation and long-term survival. In addition, studies are still needed on the optimal combination patterns of radiotherapy and immunotherapy and the precise efficacy evaluation, etc.

    Table and Figures|Reference|Related Articles|Metrics|Comments0
    Interpretation of 2023 2nd NCCN clinical practice guidelines in oncology-pancreatic adenocarcinoma
    CHEN Jiahao, JIANG Chongyi
    Journal of Surgery Concepts & Practice 2024, 29 (01): 10-13. DOI:10.16139/j.1007-9610.2024.01.03
    Abstract797 HTML5 PDF(pc)(860KB)( 1620 Save

    Pancreatic adenocarcinoma, a severe digestive malignancy, is characterized by its poor prognosis. The National Comprehensive Cancer Network (NCCN) persistently refines its guidelines, integrating cutting-edge evidence-based medical insights to standardize the diagnostic and therapeutic strategies of pancreatic adenocarcinoma. The NCCN clinical practice guidelines in oncology-pancreatic adenocarcinoma were updated twice on May 4 and June 19, 2023, respectively. Compared to the 2022 predecessor, these two updates placed a particular emphasis on immunotherapy/targeted therapy, the introduction of NALIRIFOX regimen, and supplementary treatment protocols for patients with intermediate performance status. This article provided an interpretation of the latest updates to the NCCN clinical practice guidelines in oncology-pancreatic adenocarcinoma, integrating relevant evidence-based medical findings.

    Reference|Related Articles|Metrics|Comments0
    Interpretation of NCCN clinical practice guidelines for hepatocellular carcinoma, version 2.2023
    SHI Chunchao, WANG Kui
    Journal of Surgery Concepts & Practice 2024, 29 (02): 99-105. DOI:10.16139/j.1007-9610.2024.02.02
    Abstract824 HTML7 PDF(pc)(948KB)( 1574 Save

    The National Comprehensive Cancer Network (NCCN), as the world's leading non-profit consortium in the field of oncology, continues to update clinical practice guidelines for multiple malignancies annually and has become a benchmark for clinical practice guidelines in oncology worldwide. Currently, the NCCN clinical practice guidelines for hepatocellular carcinoma have been updated to version 2.2023, as compared with version 1.2023 of its main updates for the content of the discussion section. The NCCN guidelines for hepatobiliary cancers have been reorganized to separate guidelines for biliary tract cancers and hepatocellular carcinoma since version 1.2023. The main updates focus on tumor screening, diagnosis, surgery, adjuvant therapy, locoregional therapy, systemic therapy, and so on. The molecular testing was added for the first time. Therefore, the updates of version 1.2023 were highlighted again in the new version 2.2023. This article interpreted the new guidelines and focused on the aspects of updates.

    Table and Figures|Reference|Related Articles|Metrics|Comments0
    Construction of a prognostic Nomogram for patients with incidental gallbladder cancer
    MO Jiantao, CAO Ruiqi, REN Jiaqiang, GENG Zhimin, WU Zheng, CHENG Yali
    Journal of Surgery Concepts & Practice 2024, 29 (01): 40-45. DOI:10.16139/j.1007-9610.2024.01.07
    Abstract529 HTML5 PDF(pc)(939KB)( 1263 Save

    ObjectiveTo construct and validate an effective prognostic nomogram for the patients with incidental gallbladder cancer(IGBC).MethodsThe clinical data of 161 patients with IGBC requiring radical surgery admitted to the First Affiliated Hospital of Xi’an Jiaotong University from May 2011 to October 2022 was analyzed retrospectively. COX proportional risk regression model was used to screen for influencing factors on overall survival(OS) of IGBC. Nomogram was constructed based on independent influencing factors that affected the prognosis of IGBC patients. The concordance index(C-index) and calibration curve were used to validate the performance of the model. Receiver operating characteristic (ROC) curve analysis and decision curve analysis (DCA) were used to validate the predictive accuracy and net benefit of the plotted column chart.ResultsUnivariate COX regression analysis suggested that age, T stage, N stage, M stage, preoperative carcinoembryonic antigen(CEA), preoperative carbohydrate antigen19-9(CA19-9), preoperative red blood cell volume distribution on width coefficient of variation(RDW-CV), treatment method, and recurrence and metastasis were risk factors which affected the long-term survival of IGBC patients after radical surgery. Multivariate COX regression analysis suggested that T stage, N stage, preoperative CA19-9, preoperative RDW-CV, preoperative AST, treatment methods, and recurrence and metastasis were independent risk factors which affected the prognosis of IGBC patients. The C-index of the constructed prognostic model was 0.872. The calibration plot demonstrated good performance of the Nomogram. ROC curve analysis showed an area under the curve of 0.869, confirming a high sensitivity and specificity. A high net benefit was proven by DCA.ConclusionsThe constructed Nomogram can accurately and intuitively predict the survival probability of IGBC patients after radical surgery.

    Table and Figures|Reference|Related Articles|Metrics|Comments0
    Recent advances in subtyping of biliary tract carcinoma
    LIN Zhiwen, LIU Hongzhi, ZENG Yongyi
    Journal of Surgery Concepts & Practice 2024, 29 (02): 114-120. DOI:10.16139/j.1007-9610.2024.02.04
    Abstract458 HTML0 PDF(pc)(899KB)( 1216 Save

    Biliary tract carcinoma exhibits high heterogeneity at the genomic, epigenetic, and molecular expression levels. The patients even with the same pathological morphology and clinical stage of biliary tract malignant tumors have substantial differences in the treatment response and prognosis. Traditional pathological histology and clinical classifications are no longer sufficient to meet the demands of the precision medicine era. Molecular subtyping has the potential to provide more personalized cancer treatment strategies. It not only helps to reveal the mechanisms of tumor development and accurately predict disease prognosis, but also plays a crucial role in guiding the development of novel targeted drugs and implementing targeted therapies for specific tumors. With the ongoing development of precision medicine, the role of molecular subtyping in cancer diagnosis, treatment option, and prognosis assessment is increasingly prominent. This paper systematically reviewed the recent progress in the molecular subtyping of biliary tract malignant tumors based on domestic and international clinical and basic research.

    Reference|Related Articles|Metrics|Comments0
    Expression and clinical significance of disulfidptosis-related LncRNA in gastric cancer
    CHU Yudan, SUN Haidong, CUI Ran, ZHENG Hong
    Journal of Surgery Concepts & Practice 2024, 29 (05): 414-425. DOI:10.16139/j.1007-9610.2024.05.09
    Abstract380 HTML2 PDF(pc)(2646KB)( 1201 Save

    ObjectiveTo construct prognostic model of disulfidptosis-related LncRNA (DRLncs) and explore the mechanism of LncRNA-small nucleolar RNA host genes(SNHG4) in promoting the progression of gastric cancer.MethodsThe multi-omics features of disulfidptosis genes in gastric cancer were first analyzed based on The Cancer Genome Atlas(TCGA) database. DRLncs were further screened, and disulfidptosis related gene recurrence score (DRG-RS) model was constructed to predict the overall survival(OS) and correlation with the clinical characteristics of gastric cancer patients. Differential gene analysis, functional enrichment and the correlation between chemotherapy efficacy in high- and low-risk groups were analyzed. Cell-counting kit-8 (CCK-8) assay and migration assay confirmed thatLncRNA-SNHG4promoted the malignant phenotype of gastric cancer cells. Western Blotting assay was used to detect the signaling pathway regulated byLncRNA-SNHG4.ResultsDRG-RS model including 8 DRLncs was successfully constructed, showing good performance in predicting OS of the patients with gastric cancer. DRG-RS model was significantly correlated with tumor-related signaling pathways, clinical characteristics and drug sensitivity of gastric cancer patients.LncRNA-SNHG4expression was significantly increased in gastric cancer.LncRNA-SNHG4promoted the proliferation and migration of gastric cancer cells.LncRNA-SNHG4promoted the activation ofWntsignaling pathway in gastric cancer cells.ConclusionsThe DRG-RS model constructed in our study can stratify the prognosis of gastric cancer, and is closely related to malignant characteristics and chemotherapy efficacy of gastric cancer patients. The expression ofLncRNA-SNHG4significantly increased in gastric cancer tissues, andLncRNA-SNHG4promoted the malignant phenotype of gastric cancer cells through theWntsignaling pathway, suggesting thatLncRNA-SNHG4may play an important role in the progression of gastric cancer.

    Table and Figures|Reference|Related Articles|Metrics|Comments0
    Progress in research of the risk factors of lymph node metastasis in T1 stage colorectal cancer
    CHEN Fangqian, FENG Wenqing, ZHAO Jingkun, ZONG Yaping, LU Aiguo
    Journal of Surgery Concepts & Practice 2024, 29 (04): 358-364. DOI:10.16139/j.1007-9610.2024.04.14
    Abstract455 HTML8 PDF(pc)(985KB)( 1177 Save

    Colorectal cancer is one of the common malignant tumors of the digestive tract. With the popularization of screening methods and advancement of endoscopic technology, an increasing number of T1 stage colorectal cancers can be discovered. Accurately predicting lymph node metastasis risk is significantly important for guiding clinical treatment decisions, reducing complications and mortality. Current research on risk factors for lymph node metastasis in T1 stage colorectal cancer covers multiple aspects including clinical pathological features, molecular phenotypes and genetic characteristics. Some studies have built prediction models by integrating these factors, which show higher sensitivity, specificity and accuracy compared to current clinical guidelines. These models provide valuable experience for clinical practice.

    Reference|Related Articles|Metrics|Comments0
    Application of 21-Gene test in adjuvant radiotherapy for early breast cancer
    TANG Xiaolu, HUA Xin, CAO Lu, CHEN Jiayi
    Journal of Surgery Concepts & Practice 2024, 29 (03): 270-276. DOI:10.16139/j.1007-9610.2024.03.15
    Abstract534 HTML2 PDF(pc)(895KB)( 1100 Save

    Breast cancer is the most common malignant tumor in women. With the development of genomics technology and medical frontier technology, the systemic treatment of breast cancer has gradually entered the era of personalized medicine. However, the decision-making of adjuvant radiotherapy for breast cancer still mainly relies on traditional clinicopathological factors, and there is a lack of scientific and reliable tools to guide precise radiotherapy in different populations. Hormone receptor (HR) positive/human epidermal growth factor receptor 2 (HER2) negative breast cancer is the most common molecular subtype of breast cancer. The 21-Gene recurrence score (RS) test (Oncotype Dx™, Genomic Health, Redwood City, CA) is a commercially available genomic test for breast cancer. In this article, we reviewed the current research evidence on the use of 21-Gene RS test for radiotherapy decision-making in HR-positive HER2-negative early breast cancer. Current clinical studies support the predictive value of 21-Gene RS test for adjuvant radiotherapy, and several large-scale prospective clinical studies in this area are underway.

    Table and Figures|Reference|Related Articles|Metrics|Comments0
    Correlationship between total proteins SUMOylation and papillary thyroid carcinoma in males
    WU Qiao, LIU Wei, ZHENG Jiaojiao, WANG Cong, AI Zhilong
    Journal of Surgery Concepts & Practice 2024, 29 (04): 336-344. DOI:10.16139/j.1007-9610.2024.04.11
    Abstract410 HTML5 PDF(pc)(8797KB)( 842 Save

    ObjectiveTo investigate the relationship between protein SUMOylation level and the prognosis of papillary thyroid carcinoma(PTC) in males.MethodsProtein SUMOylation levels in PTC was analyzed by bioinformatics based on GTEx and TCGA databases and validated by immunohistochemical staining and Western blotting in our clinical pairs specimens. The mRNA expression of the protein SUMOylation associated genes were measured by fluorescent quantitative real-time polymerase chain reaction (qRT-PCR) in surgical pairs specimens.ResultsThe expression level of SUMOylation in the tumor tissues of PTC showed an elevated trend(P<0.05), and was associated with poor prognosis of the patients by TCGA and GTEx databases analysis(P=0.021). In the clinical samples of our hospital, it was verified that the level of SUMOylation in tumor tissues was higher than that of the paired non-tumor tissues(P<0.05). However, qRT-PCR showed no significant changes in the transcriptional level of the protein SUMOylation associated genes in most cases.ConclusionsProtein SUMOylation in thyroid tumor tissues were higher than that in paired non-tumor tissues, and the higher SUMOylation levels levels in tumor tissues were, the shorter overall survival time of the patients was.

    Table and Figures|Reference|Related Articles|Metrics|Comments0
    Clinical significance of combination of anti-angiogenesis, immune checkpoint inhibitors and chemotherapy in the neoadjuvant treatment of locally advanced gastric cancer
    ZHU Zhenggang
    Journal of Surgery Concepts & Practice 2024, 29 (02): 132-137. DOI:10.16139/j.1007-9610.2024.02.07
    Abstract534 HTML2 PDF(pc)(937KB)( 793 Save

    The combination of anti-angiogenesis, immune checkpoint inhibitors(ICIs) and chemotherapy(target-immune-chemo) has achieved initial results in the comprehensive treatment of gastric cancer. Experimental studies have shown that among various determinants of tumor immunotherapy, tumor microenvironment (TME) plays a crucial role in affecting ICIs efficacy. The biological mechanism leading to immunosuppressive TME is multi-factorial and very complex, but one of clear and important mechanisms is the influence of abnormal neoangiogenesis in tumors. The use of low-dose targeted tumor angiogenesis drugs (such as anti-VEGF /VEGFR monoclonal antibody, etc.) is expected to make tumor vessels normalization and reverse immunosuppressive TME to immunesupportive TME, so as to play synergistic, complementary, anti-tumor effects with ICIs and chemotherapy drugs. Perioperative treatment of locally advanced gastric cancer (LAGC) has become an indispensable and important strategy in surgical comprehensive treatment of gastric cancer. In recent years, a therapeutic combination regimen of anti-angiogenesis, ICIs and chemotherapy (target-immune-chemo) has been clinically applied in the perioperative treatment of LAGC, and the preliminary efficacy [pathologic complete response(pCR), major pathological response(MPR), tumor regression grade(TRG) and treatment-related adverse events(TRAEs), etc.] has shown encouraging results. This article reviewed the relevant clinical research results and made a summary and analysis.

    Reference|Related Articles|Metrics|Comments0
    Progress in the treatment of colonic diverticular diseases
    KONG Lei, YANG Huali
    Journal of Surgery Concepts & Practice 2024, 29 (01): 87-92. DOI:10.16139/j.1007-9610.2024.01.14
    Abstract535 HTML6 PDF(pc)(881KB)( 785 Save

    The incidence of colonic diverticular disease is increasing significantly and is showing a trend of youthfulness. The treatment of colonic diverticulum disease mainly involves drugs, including antibiotics, rifaximin, and mesalazine. In addition, probiotics and dietary fiber are believed to have a positive impact on the treatment of diverticular diseases. When it progresses to acute complicated diverticulitis, surgical treatment becomes a necessary means. Up to now, our country has not formulated standards and guidelines of the diagnosis and treatment for colonic diverticulitis.

    Reference|Related Articles|Metrics|Comments0
    Etiology, classification and diagnosis of congenital biliary dilatation
    GAO Zhenhua, WU Shuodong
    Journal of Surgery Concepts & Practice 2024, 29 (02): 182-185. DOI:10.16139/j.1007-9610.2024.02.15
    Abstract670 HTML15 PDF(pc)(848KB)( 741 Save

    The etiology of congenital biliary dilatation (CBD) is still unclear. Currently, abnormal pancreatico-bile duct confluence is the mainstream theory. In terms of classification, Todani classification is the most widely used. On the other hand, Dong's classification which proposed by Dong Jiahong and his colleagues has guiding significance for the selection of surgical methods. CBD is difficult to detect and diagnose because of the poor specificity of clinical symptoms, and it is often necessary to make a preliminary diagnosis based on the medical history, and it is also quite dependent on the assistance of imaging. Serological examination also plays a key role in the diagnosis of CBD because of its convenience and high acceptance. This article reviewed the etiology, classification and diagnosis of CBD.

    Reference|Related Articles|Metrics|Comments0
    The role of liver microenvironment cells in colorectal cancer liver metastasis
    ZHAO Yiming, WU Zong, WANG Lu
    Journal of Surgery Concepts & Practice 2024, 29 (02): 126-131. DOI:10.16139/j.1007-9610.2024.02.06
    Abstract671 HTML2 PDF(pc)(869KB)( 696 Save

    The liver is the most common site of metastasis in patients with colorectal cancer(CRC). The liver microenvironment is a diverse assemblage of cells, which has their own unique biological characteristics and functions, supplemented by the interaction between cells, which jointly regulate the tumor microenvironment and play significant role in the occurrence and development of CRC liver metastasis. Consequently, a thorough investigation of the molecular mechanisms underlying CRC liver metastasis is imperative for comprehension of tumor progression, prediction of metastasis risk, and the development of innovative therapeutic strategy. This paper delved into the cellular constituents of the liver tumor microenvironment, elucidating the roles and influences of diverse cell types in the process of CRC liver metastasis, offering fresh insights and strategies for the diagnosis and management of CRC liver metastasis.

    Reference|Related Articles|Metrics|Comments0
    Advantages and advances in neoadjuvant therapy of pancreatic cancer
    HU Binwei, SHEN Baiyong
    Journal of Surgery Concepts & Practice 2024, 29 (01): 74-80. DOI:10.16139/j.1007-9610.2024.01.12
    Abstract562 HTML8 PDF(pc)(811KB)( 593 Save

    Due to the characteristics of the insidious onset, difficult early diagnosis and high malignancy of pancrea-tic cancer, only a minority of patients still have the chance of surgical resection at the time of diagnosis. In recent years, chemotherapy-based preoperative neoadjuvant therapy has been increasingly applied to pancreatic cancer without distant metastases to help achieve tumor downstaging, increase R0 resection rate and improve patient survival. A large number of clinical trials have proven the advantages of neoadjuvant therapy for pancreatic cancer, but there are still many issues to be gradually addressed by further research to reach a consensus.

    Table and Figures|Reference|Related Articles|Metrics|Comments0
    Interpretation of surgical procedure standard of conformal sphincter-preservation operation for low rectal cancer (2023 edition)
    ZHANG Wei
    Journal of Surgery Concepts & Practice 2024, 29 (03): 217-219. DOI:10.16139/j.1007-9610.2024.03.06
    Abstract504 HTML5 PDF(pc)(821KB)( 577 Save

    In this paper we interpretated the background aboutStandardized surgical procedure of conformal sphincter-preservation operation (CSPO) for low rectal cancer (2023 edition), and several key issues need to be attention, for example, the definition of conformal resection, the clarity of relevant anatomical concepts, the functional advantages of CSPO, the main differences between CSPO and intersphincteric resection(ISR), the clinical value and indications, the principles and details of surgery, and the key issues of perioperative nursing.

    Reference|Related Articles|Metrics|Comments0
    Systemic therapy alters the landscape of surgery in hepatocellular carcinoma: opportunities and challenges
    SHAO Weiqing, LU Lu, QIN Lunxiu
    Journal of Surgery Concepts & Practice 2024, 29 (02): 93-98. DOI:10.16139/j.1007-9610.2024.02.01
    Abstract453 HTML4 PDF(pc)(926KB)( 559 Save

    Surgery is still the first choice for patients with hepatocellular carcinoma(HCC). However, about 70% of HCC patients in China are first diagnosed in the advanced stage and have lost the opportunity for surgery. Recently, the rapid development of systematic therapy has brought new hope for patients with advanced HCC. The combination of molecular targeted therapy and immunotherapy with or without local therapy significantly improves the survival of advanced HCC and alters the landscape of surgical treatment in advanced HCC. In addition, systemic therapy also brings new opportunities for perioperative treatment of HCC patients. Conversion therapy, neoadjuvant therapy, and postoperative adjuvant therapy can increase the chances of surgical treatment, reduce the risk of postoperative metastasis and recurrence, and prolong the overall survival of HCC patients. Systematic therapy based on molecular targeted therapy and immunotherapy has been applied through the whole process of HCC surgical treatment, and has completely altered the surgery paradigm of HCC. However, further research is needed to determine the optimal combination protocol, screen the sensitive populations, address drug resistance, and reduce systemic adverse events.

    Reference|Related Articles|Metrics|Comments0
    Application of pylorus-preserving gastrectomy in surgical treatment for early gastric cancer and interpretation of guidelines and consensus
    YU Suyue, LU Aiguo
    Journal of Surgery Concepts & Practice 2024, 29 (01): 81-86. DOI:10.16139/j.1007-9610.2024.01.13
    Abstract429 HTML2 PDF(pc)(873KB)( 550 Save

    Endoscopic resection (ER) and laparoscopic surgery are the main methods for treatment of early gastric cancer (EGC). Radical gastrectomy(RG) and lymph node dissection are required for the patients who don’t meet the indications of ER, but it may cause postoperative stomach dysfunction and reduce quality of life (QOL). Pylorus-preserving gastrectomy (PPG) is one of the function-preserving gastrectomy for EGC. The short-term complications of PPG are equal to that of RG and it is also beneficial to long-term nutritional status and QOL. The 5-year survival rate of PPG is similar to that of distal subtotal gastrectomy (DSG) according to a retrospective study of the matched cohort. But delayed gastric emptying (DGE) is a common problem in the short and long term after PPG. The limited lymph node dissection of PPG makes its application not widely promoted. Sentinel node navigation surgery (SNNS) may provide more personalized and minimally invasive surgery, in order to preserve the gastric function to the maximum extent.

    Reference|Related Articles|Metrics|Comments0
Baidu
map